REACH: Late Pre-Registration ends in November 2009 for some chemicals and companies
The final deadline for the pre-registration of certain chemical substances and high volume manufacturers and importers is on 30 November 2009. This deadline applies to companies within the first 6 months of manufacturing, importing or using* a phasein substance that needs to be registered by 30 November 2010
A phase in substances needs to be registered by a manufacturer or importer by 30 November 2010 if it is:
• manufactured or imported in the European Union in quantities of 1 000 tonnes or more per year;
• classified as carcinogenic, mutagenic or toxic to reproduction (category 1 or 2) and manufactured or imported in the EU, in quantities of 1 tonne or more per year;
• classified as very toxic to aquatic organisms which may cause long-term adverse effects in the aquatic environment (R50/53) and manufactured or imported in the EU in quantities reaching 100 tonnes or more per year.
(*) using in this context means producing articles, or importing for the first time an article containing a phase-in substance that requires registration.
Other news from the department politics & laws
Most read news
More news from our other portals
Last viewed contents
Epigenomics AG Receives Allowances for Key Patents in Europe - Patents cover biomarker mPITX2 for prostate and breast cancer indications
Measuring chemistry: local fingerprint of hydrogen bonding captured in experiments
Analytik Jena aquires majority of distributor in Romania - Analytik Jena took over 70% of the company shares of a Romanian company based on a cash-share deal.
Nature-inspired coatings could power tiny chemistry labs for medical testing and more - Researchers develop polymer coating that enables low surface tension liquids to be transported over distances 15 times longer than currently possible, without losing any of the liquid
BOSELLO now fully part of the ZEISS Group - BOSELLO HIGH TECHNOLOGY becomes Carl Zeiss X-ray Technologies Srl
Destination China as Level Sensors and Transmitters Markets Make a Comeback - Increased investments in manufacturing and greater automated production to fuel demand in emerging economies
New study supports use of PCA3-based test for prostate cancer diagnosis - European commercialization in progress
European multi-center study suggests PCA3 test more accurate for prostate cancer
Vibrations key to efficiency of green fluorescent protein - Charting femtosecond energy flow could aid redesign of molecules to improve light capture
Entire T-cell receptor repertoire sequenced revealing extensive and unshared diversity
Chiral Technologies Europe Acquires ChromTech Ltd. of U.K.
